Blood pressure and survival in long-term hemodialysis patients with and without polycystic kidney disease
Open Access
- 1 December 2010
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal Of Hypertension
- Vol. 28 (12), 2475-2484
- https://doi.org/10.1097/hjh.0b013e32833e4fd8
Abstract
In maintenance dialysis patients, low blood pressure (BP) values are associated with higher death rates when compared with normal to moderately high values. This 'hypertension paradox' may be related to comorbid conditions. Dialysis patients with polycystic kidney disease (PKD) usually have a lower comorbidity burden and greater survival. We hypothesized that in PKD dialysis patients, a representative of a healthier dialysis patient population, high BP is associated with higher mortality. Time-dependent survival models including after multivariate adjustment were examined to assess the association between prehemodialysis and posthemodialysis BP and all-cause mortality in a 5-year cohort of 67 085 non-PKD and 1579 PKD hemodialysis patients. In PKD patients, low prehemodialysis and posthemodialysis SBPs were associated with increased mortality, whereas high prehemodialysis DBP was associated with greater survival. Fully adjusted death hazard ratios (and 95% confidence levels) for prehemodialysis and posthemodialysis BP of less than 120 mmHg (reference 140 to <160 mmHg) were 1.30 (1.06-1.92) and 1.45 (1.04-2.02), respectively, and for prehemodialysis DBP of 80 mmHg or more (reference 70 to <80 mmHg) was 0.68 (0.49-0.93, all P values <0.05). Similar associations were observed in non-PKD patients. In pooled analyses, within each commensurate BP stratum, PKD patients exhibited superior survival to non-PKD patients. Among hemodialysis patients, those with PKD display a similar BP paradox as those without PKD, even though within each BP category PKD patients maintain superior survival. Randomized clinical trials are needed to define optimal blood pressure targets in the hemodialysis population.Keywords
This publication has 44 references indexed in Scilit:
- Management of ESRD in Patients With Autosomal Dominant Polycystic Kidney DiseaseAdvances in Chronic Kidney Disease, 2010
- Blood Pressure Components and the Risk for End-Stage Renal Disease and Death in Chronic Kidney DiseaseClinical Journal of the American Society of Nephrology, 2009
- Quality of Life in Autosomal Dominant Polycystic Kidney Disease Patients not yet on DialysisClinical Journal of the American Society of Nephrology, 2009
- The association between BP and mortality in patients on chronic peritoneal dialysisNephrology Dialysis Transplantation, 2005
- Reverse Epidemiology of Hypertension and Cardiovascular Death in the Hemodialysis PopulationHypertension, 2005
- Exercise blood pressure, cardiac structure, and diastolic function in young normotensive patients with polycystic kidney disease: A prehypertensive stateAmerican Journal of Kidney Diseases, 2004
- Survival after end-stage renal disease in autosomal dominant polycystic kidney disease: Contribution of extrarenal complications to mortalityAmerican Journal of Kidney Diseases, 2001
- Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal diseaseKidney International, 1996
- Outcome of renal replacement therapy in autosomal dominant polycystic kidney diseaseNephrology Dialysis Transplantation, 1996
- Autosomal dominant polycystic kidney disease--the patient on renal replacement therapyNephrology Dialysis Transplantation, 1996